Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

merous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products including NUVIGIL for the treatment of schizophrenia; interpretation of clinical results; prospects for regulatory approval, including with respect to TREANDA and NUVIGIL; manufacturing development and capabilities; market prospects for its products; sales, adjusted net income and basic adjusted income per common share guidance for the first quarter and full-year 2008; and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward- looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law.
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: ... in the development, manufacturing, and marketing of branded,generic ... 105 of,its drugs have been included in China,s ... China,s Ministry of Human Resources and Social,Security on ...
(Date:12/2/2009)... life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among ... ... (PRWEB) December 2, 2009 -- The ... designer and manufacturer of high-performance CCD and EMCCD cameras for ...
(Date:12/1/2009)... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... of approximately $57 million, as compared with $69 million for ... results was the first of two installment payments of $12.5 ... results was a one-time $1.8 million payment from Genentech for ...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
... China, May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech ... device research,and development outsourcing company with operations ... announced that it has appointed Dr. Peng ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior ...
... In Europe, Less Screening and Treatment, and an Apparent Higher ... of Hip Fracture Than in North America and Australia, ... one in four women surveyed from Europe, North America, and,Australia ... of 45,years. Among women considered to be at high risk ...
... Inc. (Nasdaq:,BHRT) announced that on May 21, 2008 ... (the "Nasdaq Letter") advising that, for the last ... listed securities,had been below the minimum $50,000,000 requirement ... to Nasdaq Marketplace Rule,4450(b)(1)(A). Furthermore, Nasdaq stated that ...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 3Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 4Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 2
(Date:12/3/2009)... to learn new information and adapt to changes in our ... to lie in the minute junctions where nerve cells communicate, ... researchers. The study is published online this week in the ... Wen-Biao Gan, PhD, associate professor of physiology and neuroscience at ...
(Date:12/3/2009)... infections are caused by many bacterial cells that signal each ... sensing because many bacteria must be present to start the ... that the very first stage of staph infection, when bacteria ... a single cell and that this individual process can be ...
(Date:12/3/2009)... measured CO2 levels for the past three years in ... area near Valladolid. The results, which are the first ... the levels rose "significantly" between 2002 and 2005. , ... to find out about carbon dioxide (CO2) levels, and ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 1The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 2The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 3The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 4The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 5Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 1Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 2Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 3Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 1Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 2Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 3Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 4
... McKnight Brain Institute of the University of Florida have ... diseases by plundering the secrets of regeneration from creatures ... starfish and flatworms. , Fueled by about $6 million ... "The Regeneration Project" will connect scientists who work with ...
... medical practice that an antiretroviral drug widely used to treat ... own in patients co-infected with HIV. Their findings demonstrate ... drugs used to treat the AIDS virus. , "Our results ... has been shown to be active against HIV - it ...
... snakes are born with poisonous bites they use for defense. ... , What if they could borrow a dose of poison ... That's exactly what happens in the relationship between an Asian ... of researchers funded by the National Science Foundation (NSF) Division ...
Other Biology News:Research project tackles 'regeneration' gap 2Research project tackles 'regeneration' gap 3Widely used hepatitis B drug spurs HIV drug resistance 2Widely used hepatitis B drug spurs HIV drug resistance 3Nonvenomous Asian snakes 'borrow' defensive poison from toxic toads 2
... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... DNA polymerase is an antibody-mediated ... both conventional and real-time PCR ... at a concentration of 5 ... 5,000 units polymerase, 25 ml ...
... the formation of a phosphodiester bonds between ... duplex DNA molecules or between oligonucleotides which ... at 45 - 65?. Tfi DNA Ligase ... temperatures than conventional DNA ligases, Thus, Tfi ...
... GELase™ Agarose Gel-Digesting Preparation contains a unique ... simple, quantitative recovery of intact DNA and ... gels following electrophoresis in TAE, TBE, MOPS, ... digested directly in the TAE, TBE, MOPS, ...
Biology Products: